GlassScriptPhysician profile
Lisa G King
NPI 1073545885
$7,519.84
in general payments reported to CMS, 2019-2025
45 companies · $1,741 in 2025
The $1,741 reported for 2025 was more than what 92% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $636 · 2020: $507 · 2021: $49.72 · 2022: $1,437 · 2023: $1,630 · 2024: $1,518 · 2025: $1,741.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,802 · Education: $88.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,801.74 |
| Education | $88.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,019.16 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,008.83 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $787.91 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $590.36 | 2019-2025 | |
| Lilly USA, LLC | $554.46 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Otsuka America Pharmaceutical, INC. | $394.36 | 2023-2025 | Rexulti |
| Novartis Pharmaceuticals Corporation | $299.18 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $298.19 | 2020-2025 | Trintellix |
| Bayer Healthcare Pharmaceuticals INC. | $288.16 | 2022-2025 | |
| Amgen INC. | $242.46 | 2019-2025 | Repatha, Otezla, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $235.93 | 2019-2025 | Jardiance |
| Glaxosmithkline, LLC. | $183.55 | 2019-2025 | Trelegy Ellipta |
| Currax Pharmaceuticals LLC | $165.13 | 2020-2024 | Nexletol, Contrave, Nexlizet |
| Astellas Pharma US INC | $138.68 | 2019-2025 | Veozah |
| Eisai INC. | $100.90 | 2024-2025 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.